Biomedical Engineering Reference
In-Depth Information
Acknowledgements Authors thank the Department of Pharmaceuticals, Ministry of Chemical
and Fertilizers, Govt. of India, New Delhi and CSIR, New Delhi for the financial support.
Moreover, authors are thankful of Mr. Shivsharan Balbhim Kharatmal for his critical help in
preparation of this article.
References
1. Swartz KJ (2004) Towards a structural view of gating in potassium channels. Nat Rev
Neurosci 5:905-916
2. Bezanilla F (2008) How membrane proteins sense voltage. Nat Rev Mol Cell Biol 9:323-332
3. Zamponi GW, Feng ZP, Zhang L et al (2009) Scaffold-based design and synthesis of potent
N-type calcium channel blockers. Bioorg Med Chem Lett 19:6467-6472
4. Hancox JC, McPate MJ, El Harchi A et al (2008) The hERG potassium channel and hERG
screening for drug-induced torsades de pointes. Pharmacol Ther 119:118-132
5. Gussak I, Litwin J, Kleiman R et al (2004) Drug-induced cardiac toxicity: emphasizing the
role of electrocardiography in clinical research and drug development. J Electrocardiol
37:19-24
6. Durdagi S, Subbotina J, Lees-Miller J et al (2010) Insights into the molecular mechanism of
hERG1 channel activation and blockade by drugs. Curr Med Chem 17:3514-3532
7. Witchel HJ (2010) Drug-induced hERG Block and Long QT Syndrome. Cardiovasc
Ther 1-9
8. Zareba W (2007) Drug induced QT prolongation. Cardiol J 14:523-533
9. Abbott GW, Roepke TK (2009) HERG biosynthesis: the positive influence of negative
charge. Am J Physiol Heart Circ Physiol 296:H1211-H1212
10. Ahrendt E, Braun JE (2010) Channel triage: emerging insights into the processing and
quality control of hERG potassium channels by DnaJA proteins 1, 2 and 4. Channels (Austin)
4:335-336
11. Mannikko R, Overend G, Perrey C et al (2010) Pharmacological and electrophysiological
characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium
channel. Br J Pharmacol 159:102-114
12. Cui J, Melman Y, Palma E et al (2000) Cyclic AMP regulates the HERG K(+) channel by
dual pathways. Curr Biol 10:671-674
13. Thomsen MB, Volders PG, Beekman JD et al (2006) Beat-to-Beat variability of repolariza-
tion determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de
pointes. J Am Coll Cardiol 48:1268-1276
14. Pages G, Torres AM, Ju P et al (2009) Structure of the pore-helix of the hERG K(+) channel.
Eur Biophys J 39:111-120
15. Alabi AA, Bahamonde MI, Jung HJ et al (2007) Portability of paddle motif function and
pharmacology in voltage sensors. Nature 450:370-375
16. Perrin MJ, Subbiah RN, Vandenberg JI et al (2008) Human ether-a-go-go related gene
(hERG) K+ channels: function and dysfunction. Prog Biophys Mol Biol 98:137-148
17. Antzelevitch C (2007) Ionic, molecular, and cellular bases of QT-interval prolongation and
torsade de pointes. Europace 9(Suppl 4):iv4-iv15
18. Baumgartner D, Scholl-Burgi S, Sass JO et al (2007) Prolonged QTc intervals and decreased
left ventricular contractility in patients with propionic acidemia. J Pediatr 150:192-197, 197.e1
19. Zhou Z, Gong Q, Ye B et al (1998) Properties of HERG channels stably expressed in HEK
293 cells studied at physiological temperature. Biophys J 74:230-241
20. Li X, Xu J, Li M (1997) The human delta1261 mutation of the HERG potassium channel
results in a truncated protein that contains a subunit interaction domain and decreases the
channel expression. J Biol Chem 272:705-708
